Advertisement
YOU ARE HERE: LAT HomeCollectionsContact Lenses
IN THE NEWS

Contact Lenses

SPORTS
August 6, 2009 | Ben Bolch
Jason Schmidt hit Craig Counsell on the lower leg with a 71-mph curveball, and the Dodgers' pitcher was done. Schmidt wasn't forced from the Dodgers' 4-1 loss to Milwaukee in the fourth inning Wednesday night at Dodger Stadium because he was ejected or had exacerbated tensions between the teams. The veteran right-hander had merely lost control of a pitch -- and an inning -- that sent the Dodgers to their third defeat in their last four series.
Advertisement
ENTERTAINMENT
December 14, 2008 | Cristy Lytal, Lytal is a freelance writer.
If the eyes are the windows into the soul, then Kevin Carter has the power to draw the blinds. As a special effects contact lens painter, he can create everything from cataract-ridden eyes to the supernatural peepers of the living dead. Raised in Medford, Ore., and Sonoma, Calif., Carter got hooked on horror films early on. "I loved the 'Friday the 13th' movies and Freddy Krueger in 'A Nightmare on Elm Street' and stuff like that," he recalls.
BUSINESS
August 5, 2007 | From Times Wire Services
The Food and Drug Administration said it was concerned that consumers were still using a contact lens solution made by Advanced Medical Optics Inc. of Santa Ana that was recalled earlier this year. Regulators said several new cases of the potentially deadly infection known as Acanthamoeba keratitis, linked to the product, had been reported to the U.S. Centers for Disease Control and Prevention.
BUSINESS
June 28, 2007 | From Times Wire Services
Staar Surgical Co., a Monrovia-based maker of implantable contact lenses, said it had received a letter from the Food and Drug Administration warning the company that its clinical study procedures did not comply with federal rules.
BUSINESS
May 26, 2007 | Daniel Yi, Times Staff Writer
A contact-lens solution made by Santa Ana-based Advanced Medical Optics Inc. has been linked to a serious eye infection that can lead to blindness, the Wall Street Journal reported on its website Friday. Health investigators with the U.S. Centers for Disease Control and Prevention have linked bacterial infections to Advanced Medical Optics' Complete MoisturePlus solution, the website said. Company and CDC officials could not be reached for comment.
BUSINESS
November 7, 2006 | From the Associated Press
Bausch & Lomb Inc. failed to formally report nearly three dozen foreign cases of fungal eye infections later linked to one of its contact lens solutions, according to a federal warning letter. Bausch & Lomb didn't submit the 35 serious injury reports by April 7, as required by law, after Singapore health officials had alerted the Rochester, N.Y., company, the Food and Drug Administration said in the letter.
BUSINESS
August 23, 2006 | From Reuters
Bausch & Lomb Inc.'s global recall of a popular contact lens solution in May appears to have stopped the spread of a serious eye infection, but U.S. scientists still do not know what caused the outbreak, according to a study released Tuesday. Researchers at the U.S.
BUSINESS
May 18, 2006 | From the Associated Press
Bausch & Lomb Inc. said it began discussions with U.S. health regulators within days of receiving reports in February of an unusual incidence of severe fungal infections among contact lens wearers in Singapore. The Food and Drug Administration said in a preliminary report that the eye-care company failed to properly notify the agency within the mandatory 30 days about 35 cases of potentially blinding Fusarium keratitis infections among people using lens cleaners in Singapore.
BUSINESS
May 17, 2006 | From Bloomberg News
Bausch & Lomb Inc. delayed telling U.S. regulators about 35 cases of a blinding eye infection in Singapore linked to its recalled ReNu with MoistureLoc contact lens cleaner, the Food and Drug Administration said Tuesday. The eye-care company waited more than a month before reporting the cases and failed to notify the agency in writing that the product had been withdrawn in February from the Singapore and Hong Kong markets, the FDA said Tuesday in a report.
Los Angeles Times Articles
|